Multidrug-resistant tumor cells with decreased malignancy: A role for integrin αvβ3

Biochemical and Biophysical Research Communications

Volumn 316, Issue 4, 2004, Pages 1173-1177

  Kozlova, Nadezhda I ^a   Morozevich, Galina E ^a   Shtil, Alexander A ^b   Berman, Albert E ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

Extracellular matrix; Integrins; Invasion; Metastasis; Multidrug resistance

Indexed keywords

VITRONECTIN RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; ATTENUATION; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DENATURATION; DOWN REGULATION; ENZYME ACTIVITY; FIBROBLAST; HAMSTER; METASTASIS; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

ANIMALS; CELL LINE, TUMOR; CRICETINAE; DRUG RESISTANCE, MULTIPLE; EXTRACELLULAR MATRIX; INTEGRIN ALPHAVBETA3; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; SARCOMA, AVIAN;

ANIMALIA; CRICETINAE;

EID: 1642311224     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.03.004     Document Type: Article

References (31)

1. Laing N.M., Tew K.D. Drug resistance to chemotherapy: mechanisms. Encyclopedia of Cancer. 1:1997;560-570.
2. Chowdhary S.A., List A.F. Drug resistance: overview of mechanisms. Encyclopedia of Cancer. 1:1997;610-620.
3. Elliott T., Sethi T. Integrins and extracellular matrix: a novel mechanism of multidrug resistance. Expert Rev. Anticancer Ther. 2:2002;449-459.
4. Damiano J.S., Cress A.E., Hazlehurst L.A., Shtil A.A., Dalton W.S. Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood. 93:1999;1658-1667.
5. Damiano J.S., Hazlehurst L.A., Dalton W.S. Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation. Leukemia. 15:2001;1232-1239.
6. Matsunaga T., Takemoto N., Sato T., Takimoto R., Tanaka I., Fujimi A., Akiyama T., Kuroda H., Kawano Y., Kobune M., Kato J., Hirayama Y., Sakamaki S., Kohda K., Miyake K., Niitsu Y. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease in acute myelogenous leukemia. Nat. Med. 9:2003;1158-1165.
7. Hazlehurst L.A., Landowski T.H., Dalton W.S. Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death. Oncogene. 22:2003;7396-7402.
8. Hood J.D., Cheresh D.A. Role of integrins in cell invasion and migration. Nature Rev. Cancer. 2:2002;91-100.
9. Felding-Habermann B., Fransvea E., O'Toole T.E., Manzuk L., Faha B., Hensler M. Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells. Clin. Exp. Metastasis. 19:2002;427-436.
10. Tani N., Higashiyama S., Kawaguchi N., Madarame J., Ota I., Ito Y., Ohoka Y., Shiosaka S., Takada Y., Matsuura N. Expression level of integrin alpha 5 on tumour cells affects the rate of metastasis to the kidney. Br. J. Cancer. 88:2003;327-333.
11. Sedlak J., Sedlakova O., Hlavcak P., Hunakova L., Bizik J., Grofova M., Chorvath B. Cell surface phenotype and increased penetration of human multidrug-resistant ovarian carcinoma cells into in vitro collagen-fibroblasts matrix. Neoplasma. 43:1996;389-395.
12. Liang Y., Meleady P., Cleary I., McDonnel S., Connoly L., Clynes M. Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness. Eur. J. Cancer. 37:2001;1041-1052.
13. Molinari A., Calcabrini A., Meschini S., Marra M., Stringaro A., Toccacieli L., Cianfriglia M., Arancia G. What is the relationship between P-glycoprotein and adhesion molecule expression in melanoma cells? Melanoma Res. 12:2002;109-114.
14. Narita T., Kimura N., Sato M., Matsuura N., Kannagi R. Altered expression of integrins in adriamycin-resistant human breast cancer cells. Anticancer Res. 18:1998;257-262.
15. Nista A., Leonetti C., Bernardini G., Mattioni M., Santoni A. Functional role of alpha4beta1 and alpha5beta1 integrin fibronectin receptors expressed on adriamycin-resistant MCF-7 human mammary carcinoma cells. Int. J. Cancer. 72:1997;133-141.
16. Deichman G.I., Gurova K.V., Dyakova N.A. Accumulation in "normal" lungs of live tumorigenic cells during sub-cutaneous growth of weakly and highly metastasizing tumors and their in vitro sensitivity to growth regulation by normal fibroblasts. Int. J. Cancer. 59:1994;530-537.
17. Kozlova N.I., Morozevich G.E., Chubukina A.N., Berman A.E. Integrin alphavbeta3 promotes anchorage-dependent apoptosis in human intestinal carcinoma cells. Oncogene. 20:2001;4710-4717.
18. Erokhina M.V., Shtil A.A., Shushanov S.S., Sidorova T.A., Stavrovskaya A.A. Partial restoration of the actin cytoskeleton in transformed Syrian hamster fibroblasts selected for low levels of 'typical' multidrug resistance. FEBS Lett. 341:1994;295-298.
19. Berman A., Morozevich G., Karmansky I., Gleiberman A., Bychkova V. Adhesion of mouse hepatocytes to type I collagen: role of supramolecular forms and effect of proteolytic degradation. Biochem. Biophys. Res. Commun. 194:1993;351-357.
20. Kozlova N.I., Morozevich G.E., Soloveyva N.I., Vinokurova S.V., Berman A.E. Integrin expression and collagenase activity of RSV-transformed Syrian hamster fibroblasts, differing in spontaneous metastasizing. Biochem. Mol. Biol. Int. 43:1997;529-539.
21. Deichman G.I., Kluchareva T.E., Matveeva V.A., Kushlinsky N.E., Bassalyk L.S., Vendrov E.L. Clustering of discrete cell properties essential for tumorigenicity and metastasis I. Studies of Syrian hamster embryo fibroblasts spontaneously transformed in vitro. Int. J. Cancer. 44:1989;904-907.
22. J.A. Eble, Integrins - a versatile and old family of cell adhesion molecules, in: J.A. Eble, K. Kunn (Eds.), Molecular Biology Intelligence Unit. Integrin-Ligand Interaction, Chapman & Hall, New York, 1-40.
23. Filardo E.J., Brooks P.C., Deming S.L., Damsky C., Cheresh D.A. Requirement of the NPXY motif in the integrin beta 3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo. J. Cell Biol. 130:1995;441-450.
24. Ruoslahti E. RGD and other recognition sequences for integrins. Ann. Rev. Cell Dev. Biol. 12:1996;697-715.
25. Frisch S., Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124:1994;619-626.
26. Brassard D.L., Maxwell E., Malkowski M., Nagabhushan T.L., Kumar C.C., Armstrong L. Integrin alpha(v)beta(3)-mediated activation of apoptosis. Exp. Cell Res. 251:1999;33-45.
27. Levkau B., Kenagy R.D., Karsan A., Weitkamp B., Clowes A.W., Ross R., Raines E.W. Activation of metalloproteinases and their association with integrins: an auxiliary apoptotic pathway in human endothelial cells. Cell Death Differ. 9:2002;1360-1367.
28. Ria R., Vacca A., Ribatti D., Di Raimondo F., Merchionne F., Dammacco F. Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma. Haematologica. 87:2002;836-845.
29. Morini M., Mottolese M., Ferrari N., Ghiorzo F., Buglioni S., Mortarini R., Noonan D.M., Natali P.G., Albini A. The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int. J. Cancer. 87:2000;336-342.
30. Reinmuth N., Liu W., Ahmad S.A., Fan F., Stoeltzing O., Parikh A.A., Bucana C.D., Gallick G.E., Nickols M.A., Westlin W.F., Ellis L.M. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice. Cancer Res. 63:2003;2079-2087.
31. Stupack D.G., Puente X.S., Boutsaboualoy S., Storgard C.M., Cheresh D.A. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J. Cell Biol. 155:2001;459-470.